Peginterferon alfa-2b biosimilar (Intas Pharmaceuticals)

聚乙二醇干扰素α-2b生物类似药 (Intas Pharmaceuticals)

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePeginterferon alfa-2b biosimilar (Intas Pharmaceuticals)
Drug Alias Name聚乙二醇干扰素α-2b生物仿制药 (Intas Pharmaceuticals)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionImmunostimulantsInnate antiviral immune response inducersInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis CHepatitis B
Global Approved IndicationsHepatitis CHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2014/01/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesIntas Biopharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesIntas Biopharmaceuticals
Inactive CompaniesN/A
Active IndicationsHepatitis CHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeL03AB10
Related LinksN/A